Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an update.
Race Oncology Ltd announced the application for quotation of 8,760 fully paid ordinary securities on the Australian Securities Exchange. This move reflects the company’s strategic efforts to enhance its financial standing and market presence, potentially impacting its operational capabilities and offering opportunities for stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology and pharmaceutical industry, focusing on the development and commercialization of cancer treatments. It is known for its work on innovative therapies targeting various cancer types.
YTD Price Performance: -4.81%
Average Trading Volume: 84,217
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$223.2M
See more data about RAC stock on TipRanks’ Stock Analysis page.
